Items where authors include "Hamilton, E."

Article

Baird, R.D., Bermejo de Las Heras, B., Ruiz-Borrego, M. et al. (20 more authors) (2025) Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1. Clinical Cancer Research, 31 (20). pp. 4244-4254. ISSN 1078-0432

Hamilton, E., Shone, L., Reynolds, C. et al. (3 more authors) (2025) Perceptions of healthcare professionals on the use of a risk prediction model to inform atrial fibrillation screening: Qualitative interview study in English primary care. BMJ Open, 15 (2). e091675. ISSN 2044-6055

Hamilton, E., Oliveira, M., Turner, N. et al. (18 more authors) (2024) A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results. Annals of Oncology, 35 (8). pp. 707-717. ISSN 0923-7534

Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736

Ward, D.G., Nyangoma, S., Joy, H. et al. (8 more authors) (2008) Proteomic profiling of urine for the detection of colon cancer. Proteome Science, 6. 19.